FDA does a pretty good job of approving new drugs to treat cancer

It is common to hear people complain that the U.S. Food & Drug Administration (FDA) takes too long to approve new cancer therapies or that new drugs are brought to market much sooner in Europe than they are in America. A new and independent assessment of the facts actually suggests quite the opposite. … READ MORE …

European Medicines Agency approves cabazitaxel

According to a media release from Sanofi-Aventis and a report on the Reuters web site today, the European Medicines Agency (EMEA) has approved cabazitaxel (Jevtana) … READ MORE …


Get every new post delivered to your Inbox.

Join 1,455 other followers